Staccato Granisetron® (AZ 010) for the Treatment of Cyclic Vomiting Syndrome

Clinical trial NCT04645953 · COMPLETED

Trial details

NCT number: NCT04645953
Sponsor: Alexza Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cyclic Vomiting Syndrome

Start date: 2021-02-05
Primary completion: 2022-07-26
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.